Table 2: Comorbid disease processes as identified by office-based electronic medical record (N=122).
| Females (65%) | Percent (of N) | Males (35%) | Percent (of N) |
|---|---|---|---|
| NASH | 45 | NASH | 21 |
| Fatty liver | 42 | Hypertension | 20 |
| Hypertension | 41 | Fatty changes of the liver | 16 |
| Vitamin D deficiency | 36 | T2DM | 15 |
| T2DM | 33 | Hyperlipidaemia | 13 |
| Hyperlipidaemia | 25 | T2DM With hyperlipidaemia | 12 |
| Major depressive disorder | 23 | Gastro-oesophageal reflux disease | 11 |
| Gastro-oesophageal reflux disease | 23 | Hypercholesterolaemia | 9 |
| Constipation | 21 | Polyneuropathy | 8 |
| Osteoarthritis | 21 | Fatigue | 8 |
Source: Allscripts Professional EMR version 17.3.1, accessed by Luke Snedacker, Lucas Research, November 2019. Database represents patient records from one US-based endocrinology practice.
NASH = non-alcoholic steatohepatitis; T2DM = type 2 diabetes mellitus.